Neurobiological Technologies (Neurobiological Technologies) Debt-to-Equity : 0.00 (As of Sep. 2009)

Neurobiological Technologies Debt-to-Equity Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
Debt-to-Equity		Get a 7-Day Free Trial					-	-	-	-	-

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Neurobiological Technologies's Debt-to-Equity

For the Biotechnology subindustry, Neurobiological Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Debt-to-Equity falls into.

Neurobiological Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Neurobiological Technologies's Debt to Equity Ratio for the fiscal year that ended in Jun. 2009 is calculated as

Neurobiological Technologies's Debt to Equity Ratio for the quarter that ended in Sep. 2009 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Neurobiological Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description